Unlock instant, AI-driven research and patent intelligence for your innovation.

Paired antibodies for detecting novel coronavirus and their applications

A technology for detecting antibodies and pairing antibodies, which is applied in the field of immunoassays and can solve problems such as reducing the affinity of antibodies and N protein, lack of antibody combinations, and poor stability

Active Publication Date: 2021-12-14
SHANGHAI LIANGRUN BIOMEDICINE TECH CO LTD
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] However, the N protein binds to the nucleic acid, resulting in epitope shielding, and the nucleic acid PO 3 2- Negative charges also reduce the affinity between antibodies and N protein. General antibody combinations are easily affected by nucleic acids and have poor stability.
At the same time, the initial clinical screening of new coronavirus needs to be close to the sensitivity of RT-PCR virus detection, and the detection limit of N antigen is 50pg / mL or even lower. At present, there is no antibody combination to meet this clinical demand.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Paired antibodies for detecting novel coronavirus and their applications
  • Paired antibodies for detecting novel coronavirus and their applications
  • Paired antibodies for detecting novel coronavirus and their applications

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0048] Example 1 Preparation of hybridoma cell lines

[0049] Hybridoma cell strain preparation: BL-21 (DE3) strain was transformed with pET-28a -N plasmid to express N protein solublely. BALB / c mice were subcutaneously immunized with 25 μg of antigen with Freund's complete adjuvant, and Freund's incomplete adjuvant was used for the second and third immunizations. Ten days after the third immunization, blood was collected by docking the tail, and the serum titer reached 1:640,000. 30 μg N protein was administered intraperitoneally for booster immunization. After 3 days, splenocytes were taken and SP2 / 0 myeloma cells were fused with PEG at a ratio of 5:1. 1 mL of preheated 50% PEG-1450 was left to stand for 1 min, shaken slowly in a water bath for 90 s, slowly added 15 mL of DMEM medium dropwise, and kept in a water bath at 37°C for 5 min. Add serum-free DMEM medium to 40 mL, centrifuge at 1000 rpm for 5 min and discard the supernatant. Add 40 mL of preheated HAT-containing ...

Embodiment 2

[0058] Example 2 Rapid detection of chemiluminescence

[0059]N24 antibody HRP labeling: (1) Weigh 25 mg of HRP and dissolve it in 1.25% glutaraldehyde solution, and let it stand overnight at room temperature. (2) The reacted enzyme solution was eluted with Sephadex G-25 chromatographic column with normal saline. The flow rate was controlled at 1 mL / min, and the brown effluent was collected. If the volume is greater than 5 mL, concentrate to 5 mL with PEG. Place in a 25mL small beaker and stir slowly. (3) Dilute 12.5 mg of the antibody to be labeled to 5 mL with normal saline, and add it dropwise to the enzyme solution while stirring. (4) Add 0.25mL of 1M pH9.5 carbonate buffer and continue to stir for 3 hours. (5) Add 0.25 mL of 0.2M lysine, mix well, and place at room temperature for 2 hours. (6) Add an equal volume of saturated ammonium sulfate dropwise under stirring, and place at 4°C for 1 hour. (7) Centrifuge at 3000rpm for half an hour, discard the supernatant. T...

Embodiment 3

[0064] Example 3 Preparation of test card

[0065] Antibody microsphere labeling: 300nm red carboxyl microspheres (Thermo) were washed with 50mM MES pH6.0 and diluted to 1mg / mL, and then ultrasonically dispersed (Ningbo Xinzhi), the ultrasonic program was 5%, ultrasonic 2s, interval 3s, ultrasonic 3min . EDC two-step method activates carboxyl microspheres, EDC, sulfo-NHS MES solution (5mg / mL) is added with 1% (1mg / mL) microspheres, NHS:EDC:-COOH is mixed at a ratio of 5:5:1, 30 ℃ rotation activation for 30min. After washing the microspheres with 50mM HEPES pH 7.4 coupling buffer by centrifugation at 13000rpm, add 80μg of N17 antibody per mg of microspheres, rotate and couple at 37°C for 2 hours, and add 5% BSA solution for blocking.

[0066] Take the PVC bottom plate, sample pad, conjugation pad, nitrocellulose membrane and absorbent paper, lap the sample pad, conjugation pad, reaction membrane and water absorption pad on the PVC bottom plate in sequence, and coat the N24 an...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a paired antibody for detecting new coronavirus and application thereof, which includes a first detection antibody and a second detection antibody; the first detection antibody has a light chain complementarity determining region as shown in SEQ ID NO:1~3 , and the complementarity determining region of the heavy chain as shown in SEQ ID NO:4~6, the second detection antibody has the complementarity determining region of the light chain as shown in SEQ ID NO:7~9, and the complementarity determining region of the light chain as shown in SEQ ID NO:10~12 The complementarity-determining regions of the heavy chain are indicated. The present invention screens and obtains paired antibodies with the above CDR sequence, which recognize different epitopes of the N protein, and since the two antibodies recognize the non-nucleic acid binding region of the N protein, they will not be interfered by the negative charge of the nucleic acid, and they will not be interfered by the negative charge of the nucleic acid, and they will not be interfered by the negative charge of the nucleic acid, and they will not be affected by the nucleic acid antigen. In addition to compatibility, it has good stability, and at the same time, the above-mentioned paired antibody has high affinity, and the detection sensitivity of the virus N protein is high.

Description

technical field [0001] The invention relates to the technical field of immunoassay, in particular to a paired antibody for detecting novel coronavirus and its application. Background technique [0002] 2019 Novel Coronavirus (2019-nCoV), named "2019-nCoV" by the World Health Organization on January 12, 2020, and "Severe Acute Respiratory Syndrome Coronavirus 2" by the International Virus Taxonomy Committee on February 11, 2020 (SARS-CoV-2)". SARS-CoV-2 is a round or oval β-genus novel coronavirus, and respiratory droplet transmission and contact transmission are the main routes of transmission. The crowd is generally susceptible, and the incubation period is generally 3 to 7 days, and there is infectivity during the incubation period. Current detection methods for SARS-CoV-2 include lung imaging, RT-PCR, and blood antibody detection methods. RT-PCR is the gold standard method for virus diagnosis. The operation process is cumbersome and requires professional equipment and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K16/10C12N5/20G01N33/569G01N33/558G01N33/577
CPCC07K16/10G01N33/56983G01N33/558G01N33/577C07K2317/565C07K2317/56C07K2317/92C07K2317/94G01N2333/165G01N2469/10
Inventor 杨敏孙玉龙张勇王弢
Owner SHANGHAI LIANGRUN BIOMEDICINE TECH CO LTD